|
Globus Medical, Inc. (GMED) DCF Valuation
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Globus Medical, Inc. (GMED) Bundle
Simplify Globus Medical, Inc. (GMED) valuation with this customizable DCF Calculator! Featuring real Globus Medical, Inc. (GMED) financials and adjustable forecast inputs, you can test scenarios and uncover Globus Medical, Inc. (GMED) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 789.0 | 958.1 | 1,022.8 | 1,568.5 | 2,519.4 | 3,414.7 | 4,628.2 | 6,273.0 | 8,502.3 | 11,523.8 |
| Revenue Growth, % | 0 | 21.43 | 6.76 | 53.34 | 60.62 | 35.54 | 35.54 | 35.54 | 35.54 | 35.54 |
| EBITDA | 178.3 | 250.3 | 304.5 | 346.6 | 473.7 | 815.4 | 1,105.2 | 1,497.9 | 2,030.3 | 2,751.8 |
| EBITDA, % | 22.6 | 26.12 | 29.77 | 22.1 | 18.8 | 23.88 | 23.88 | 23.88 | 23.88 | 23.88 |
| Depreciation | 62.9 | 69.9 | 68.3 | 144.7 | 254.0 | 281.7 | 381.8 | 517.4 | 701.3 | 950.6 |
| Depreciation, % | 7.97 | 7.29 | 6.67 | 9.23 | 10.08 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 |
| EBIT | 115.5 | 180.4 | 236.3 | 201.9 | 219.7 | 533.7 | 723.4 | 980.5 | 1,328.9 | 1,801.2 |
| EBIT, % | 14.63 | 18.83 | 23.1 | 12.87 | 8.72 | 15.63 | 15.63 | 15.63 | 15.63 | 15.63 |
| Total Cash | 426.7 | 443.4 | 446.1 | 517.8 | 890.1 | 1,450.0 | 1,965.3 | 2,663.7 | 3,610.4 | 4,893.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 148.1 | 165.7 | 217.3 | 504.9 | 557.7 | 762.4 | 1,033.3 | 1,400.5 | 1,898.2 | 2,572.8 |
| Account Receivables, % | 18.77 | 17.29 | 21.25 | 32.19 | 22.14 | 22.33 | 22.33 | 22.33 | 22.33 | 22.33 |
| Inventories | 229.2 | 237.0 | 299.0 | 848.1 | 659.2 | 1,114.9 | 1,511.1 | 2,048.1 | 2,776.0 | 3,762.5 |
| Inventories, % | 29.04 | 24.74 | 29.23 | 54.07 | 26.17 | 32.65 | 32.65 | 32.65 | 32.65 | 32.65 |
| Accounts Payable | 18.2 | 22.0 | 36.1 | 56.7 | 75.1 | 100.5 | 136.3 | 184.7 | 250.4 | 339.3 |
| Accounts Payable, % | 2.31 | 2.29 | 3.53 | 3.61 | 2.98 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 |
| Capital Expenditure | -63.7 | -56.9 | -74.0 | -78.3 | -115.4 | -210.5 | -285.3 | -386.6 | -524.0 | -710.3 |
| Capital Expenditure, % | -8.07 | -5.94 | -7.24 | -4.99 | -4.58 | -6.16 | -6.16 | -6.16 | -6.16 | -6.16 |
| Tax Rate, % | 14.69 | 14.69 | 14.69 | 14.69 | 14.69 | 14.69 | 14.69 | 14.69 | 14.69 | 14.69 |
| EBITAT | 93.8 | 149.2 | 184.9 | 150.0 | 187.4 | 428.9 | 581.3 | 787.9 | 1,067.9 | 1,447.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -266.0 | 140.5 | 79.6 | -599.7 | 480.5 | -134.8 | 46.4 | 62.9 | 85.3 | 115.6 |
| WACC, % | 9.35 | 9.35 | 9.35 | 9.34 | 9.36 | 9.35 | 9.35 | 9.35 | 9.35 | 9.35 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 97.2 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 120 | |||||||||
| Terminal Value | 2,246 | |||||||||
| Present Terminal Value | 1,437 | |||||||||
| Enterprise Value | 1,534 | |||||||||
| Net Debt | -247 | |||||||||
| Equity Value | 1,781 | |||||||||
| Diluted Shares Outstanding, MM | 138 | |||||||||
| Equity Value Per Share | 12.92 |
What You Will Get
- Real GMED Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Globus Medical's future performance.
- User-Friendly Design: Tailored for professionals while remaining approachable for newcomers.
Key Features
- Customizable Forecast Inputs: Adjust vital metrics such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional outputs.
- High-Precision Accuracy: Leverages Globus Medical's actual financial data for credible valuation results.
- Effortless Scenario Analysis: Evaluate various assumptions and compare results with ease.
- Efficiency Booster: Remove the necessity of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for Globus Medical, Inc. (GMED).
- Step 2: Review the pre-filled financial data and forecasts for Globus Medical.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Globus Medical, Inc. (GMED)?
- Accurate Data: Up-to-date Globus Medical financials provide trustworthy valuation outcomes.
- Customizable: Tailor essential inputs like growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Ready-made calculations save you from having to build from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the medical device sector.
- User-Friendly: Simple design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for investment analysis in Globus Medical, Inc. (GMED).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Globus Medical, Inc. (GMED).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Healthcare Industry Analysts: Gain insights into how medical device companies like Globus Medical, Inc. (GMED) are valued in the market.
What the Template Contains
- Pre-Filled Data: Contains Globus Medical’s historical financials and projections.
- Discounted Cash Flow Model: An editable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Globus Medical’s profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily adjust revenue growth, profit margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.